• Latest Posts

Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology

UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic

British Biotech Tops up its Cancer Pipeline with New TCR Therapy

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

UPDATE: Novartis broadens CAR-T onslaught with FDA endorsement

Taking Cell Therapy one Step Further with this Boost Reagent

ADVERTISEMENT
Interview 16 Mar 2017

“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”

UK Immunotherapy Biotech raises Massive Funding in Series C

Novartis Relies on Biotech to keep up its Solid Financial Performance

The 8 Biggest Biotech Medical Fails of 2016 in Europe

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

ADVERTISEMENT